Rebate Reform: How Will Patients Benefit?

The debate over whether the rebate system that currently exists in the U.S. is beneficial for patients or payers or pharmacy benefit managers (PBMs) has been endless. Now, a new report from the Center for Medical Economics and Innovation at the Pacific Research...
Episode 29: What Goes Into Drug Prices

Episode 29: What Goes Into Drug Prices

On this episode of the podcast, Terry and Bob discuss what goes into a drug price. They pull the curtain to reveal the group of middlemen between drugmakers and the patient that drives up the drug prices patients pay. They highlight the bizarre system of drug rebates,...

The Ins and Outs of the 340B Drug Pricing Program 

What Is the 340B Drug Pricing Program? Established by Congress in 1992 and managed by the Health Resources and Services Administration (HRSA), the 340B Drug Pricing Program mandates drug manufacturers participating in Medicaid to provide certain outpatient drugs...